Found: 9
Select item for more details and to access through your institution.
Safety and Immunogenicity of a Live Attenuated RSV Vaccine in Healthy RSV-Seronegative Children 5 to 24 Months of Age.
- Published in:
- PLoS ONE, 2013, v. 8, n. 10, p. 1, doi. 10.1371/journal.pone.0077104
- By:
- Publication type:
- Article
A Phase 1 Trial of MSP2-C1, a Blood-Stage Malaria Vaccine Containing 2 Isoforms of MSP2 Formulated with Montanide<sup>®</sup> ISA 720.
- Published in:
- PLoS ONE, 2011, v. 6, n. 9, p. 1, doi. 10.1371/journal.pone.0024413
- By:
- Publication type:
- Article
Safety and Immunogenicity Following Administration of a Live, Attenuated Monovalent 2009 H1N1 Influenza Vaccine to Children and Adults in Two Randomized Controlled Trials.
- Published in:
- PLoS ONE, 2010, v. 5, n. 10, p. 1, doi. 10.1371/journal.pone.0013755
- By:
- Publication type:
- Article
Blood Stage Malaria Vaccine Eliciting High Antigen- Specific Antibody Concentrations Confers No Protection to Young Children in Western Kenya.
- Published in:
- PLoS ONE, 2009, v. 4, n. 3, p. 1, doi. 10.1371/journal.pone.0004708
- By:
- Publication type:
- Article
Phase 1 Trial of AMA1-C1/Alhydrogel plus CPG 7909: An Asexual Blood-Stage Vaccine for Plasmodium falciparum Malaria.
- Published in:
- PLoS ONE, 2008, v. 3, n. 8, p. 1, doi. 10.1371/journal.pone.0002940
- By:
- Publication type:
- Article
Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51.
- Published in:
- PLoS ONE, 2008, v. 3, n. 7, p. 1, doi. 10.1371/journal.pone.0002636
- By:
- Publication type:
- Article
Phase 1 Study of Two Merozoite Surface Protein 1 (MSP1<sub>42</sub>) Vaccines for Plasmodium falciparum Malaria.
- Published in:
- PLoS Clinical Trials, 2007, v. 4, n. 4, p. 01
- By:
- Publication type:
- Article
Quantitative Detection of Plasmodium falciparum DNA in Saliva, Blood, and Urine.
- Published in:
- Journal of Infectious Diseases, 2009, v. 199, n. 11, p. 1567, doi. 10.1086/598856
- By:
- Publication type:
- Article
Molecular Markers for Failure of Sulfadoxine-Pyrimethamine and Chlorproguanil-Dapsone Treatment of Plasmodium falciparum Malaria.
- Published in:
- Journal of Infectious Diseases, 2002, v. 185, n. 3, p. 380, doi. 10.1086/338566
- By:
- Publication type:
- Article